Journal of Medical Toxicology

, Volume 4, Issue 2, pp 109–114 | Cite as

Intravenous fat emulsion: A potential novel antidote

  • Danielle E. Turner-Lawrence
  • William KernsEmail author
Toxicology Reviews


Intravenous fat emulsions (IFE) are traditionally used as a component of parenteral nutrition therapy. Recently, IFE was used to resuscitate severe local anesthetic drug toxicity. This review focuses on the potential role of IFE in treatment of toxicity due to local anesthetics and other lipid-soluble drugs. The general properties of IFE, metabolic fate, and associated adverse events are described. Cases of local anesthetic toxicity treated with IFE are presented along with a discussion of the possible antidotal mechanisms. Initial investigations into the antidotal use of IFE for lipophilic central nervous and cardiovascular drug toxicity are also reviewed.


Intravenous fat emulsion cardiovascular drug toxicity antidote 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsions for clinical use.J Parenter Enteral Nutr 2006;30:351–367.CrossRefGoogle Scholar
  2. 2.
    Driscoll DF. Lipid injectable emulsions: 2006.Nutr Clin Pract 2006;21:381–386.PubMedCrossRefGoogle Scholar
  3. 3.
    Package Insert: Liposyn III 30%.2005. Ref Type: Pamphlet.Google Scholar
  4. 4.
    Geyer R. Parenteral nutrition.Physiol Rev. 1960; 40:150–186.PubMedGoogle Scholar
  5. 5.
    Lekka ME, Liokatis S, Nathanail C, Galani V, Nakos G. The impact of intravenous fat emulsion administration in acute lung injury.Am J Respir Crit Care Med 2004;169:638–644.PubMedCrossRefGoogle Scholar
  6. 6.
    Schulz PE, Weiner SP, Haber LM, Armstrong DD, Fishman MA. Neurological complications from fat emulsion therapy.Ann Neurol 1994;35:628–630.PubMedCrossRefGoogle Scholar
  7. 7.
    Hessov I, Melsen F, Haug A. Postmortem findings in three patients treated with intravenous fat emulsions.Arch Surg 1979;114:66–88.PubMedGoogle Scholar
  8. 8.
    Driscoll DF. Lipid injectable emulsions: pharmacopeial and safety issues.Pharm Res 2006;23:1959–1969.PubMedCrossRefGoogle Scholar
  9. 9.
    Fat emulsions (systemic) 9-2-1999. Ref Type: Electronic Citation.Google Scholar
  10. 10.
    Intralipid. 2007. Ref Type: Electronic Citation.Google Scholar
  11. 11.
    Traul KA, Driedger A, Ingle DL, Nakhasi D. Review of the toxicologic properties of medium-chain triglycerides.Food Chem Toxicol 2000;38:79–98.PubMedCrossRefGoogle Scholar
  12. 12.
    Klein S, Miles JM. Metabolic effects of long-chain and medium-chain triglyceride emulsions in humans.J Parenter Enteral Nutr 1994;18:436–441.CrossRefGoogle Scholar
  13. 13.
    Sehgal LR, Sehgal HLRAL, Gould SA, Moss GS. Effect of Intralipid on measurements of total hemoglobin and oxyhemoglobin in whole blood.Crit Care Med 1984;12:907–909.PubMedCrossRefGoogle Scholar
  14. 14.
    Cane RD, Harrison RA, Shapiro BA, Kavanaugh J. The spectrophotometric absorbance of Intralipid.Anesthesiology 1980;53:53–55.PubMedCrossRefGoogle Scholar
  15. 15.
    Venus B, Prager R, Patel CB, Sandoval E, Sloan P, Smith RA. Cardiopulmonary effects of Intralipid infusion in critically ill patients.Crit Care Med 1988;16:587–590.PubMedCrossRefGoogle Scholar
  16. 16.
    Venus B, Smith RA, Patel C, Sandoval E. Hemodynamic and gas exchange alterations during Intralipid infusion in patients with adult respiratory distress syndrome.Chest 1989;95:1278–1281.PubMedCrossRefGoogle Scholar
  17. 17.
    Hwang T-L, Huang S-L, Chen M-F. Effects of intravenous fat emulsion on respiratory failure.Chest 1990;97:934–938.PubMedCrossRefGoogle Scholar
  18. 18.
    Mathru M, Dries DJ, Zecca A, Fareed J, Rooney MW, Rao TL. Effects of fast vs slow intralipid infusion on gas exchange, pulmonary hemodynamics, and prostaglandin metabolism.Chest 1991;99:426–429.PubMedCrossRefGoogle Scholar
  19. 19.
    Hageman JR, McCulloch K, Gora P, Olsen EK, Pachman L, Hunt CE. Intralipid alterations in pulmonary prostaglandin metabolism and gas exchange.Crit Care Med 1983;11:794–798.PubMedCrossRefGoogle Scholar
  20. 20.
    Masclans JR, Iglesia R, Bermejo B, Pico M, Rodriguez-Roisin R, Planas M. Gas exchange and pulmonary haemodynamic responses to fat emulsions in acute respiratory distress syndrome.Intensive Care Med 1998;24:918–923.PubMedCrossRefGoogle Scholar
  21. 21.
    Faucher M, Bregeon F, Gainnier M, Thirion X, Auffray J, Papazian L. Cardiopulmonary effects of lipid emulsions in patients with ARDS.Chest 2003; 124:285–291.PubMedCrossRefGoogle Scholar
  22. 22.
    McKeen CR, Brigham KL, Bowers RE, Harris TR. Pulmonary vascular effects of fat emulsion infusion in unanesthetized sheep.J Clin Invest 1978;61:1291–1297.PubMedCrossRefGoogle Scholar
  23. 23.
    Stehr SN, Ziegeler JC, Pexa A, et al. The effects of lipid infusion on myocardial function and bioenergetics in L-bupivacaine toxicity in the isolated rat heart.Anesth Analg 2007;104:186–192.PubMedCrossRefGoogle Scholar
  24. 24.
    Morey TE, Varshney M, Flint JA, Rajasekaran S, Shah DO, Dennis DM. Treatment of local anesthetic-induced cardiotoxicity using drug scavenging nanoparticles.Nano Lett 2004;4:757–759.CrossRefGoogle Scholar
  25. 25.
    Weinberg GL, VadeBoncouer T, Gopal R, Garcia-Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats.Anesthesiology 1998;88:1071–1075.PubMedCrossRefGoogle Scholar
  26. 26.
    Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity.Reg Anesth Pain Med 2003;198–202.Google Scholar
  27. 27.
    Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest.Anesthesiology 2006;105:217–218.PubMedCrossRefGoogle Scholar
  28. 28.
    Litz RJ, Popp M, Stehr SN, Koch T. Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion.Anaesthesia 2006;61:800–807.PubMedCrossRefGoogle Scholar
  29. 29.
    Foxall G, McCahon R, Lamb J, Hardman JG, Bedforth NM. Levobupivacaine-induced seizures and cardiovascular collapse treated with Intralipid.Anaesthesia 2007;62:516–518.PubMedCrossRefGoogle Scholar
  30. 30.
    Weinberg GL. In defense of lipid resuscitation.Anaesthesia 2006;61:807–808.PubMedCrossRefGoogle Scholar
  31. 31.
    Van de Velde M, DeWolff M, Leather HA, Wouters PF. Effects of lipids on the functional and metabolic recovery from global myocardial stunning in isolated rabbit hearts.Cardiovasc Res 2000;48:129–137.PubMedCrossRefGoogle Scholar
  32. 32.
    Liedtka AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium.Circ Res 1998; 62:535–542.Google Scholar
  33. 33.
    Weinberg GL, Palmer JW, VadeBoncouer TR, Zuechner MB, Edelman G, Hoppel CL. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria.Anesthesiology 2000;92:523–528.PubMedCrossRefGoogle Scholar
  34. 34.
    Bania T, Chu J, Lyon T, Yoon JT. The role of cardiac free fatty acid metabolism in verapamil toxicity treated with intravenous fat emulsions.Acad Emerg Med 2007;14:S196-S197. Ref Type: Abstract.CrossRefGoogle Scholar
  35. 35.
    Huang JM-C, Xian H, Bacaner M. Long chain fatty acids activate calcium channels in ventricular myocytes.Proc Natl Acad Sci USA 1992;89:6452–6456.PubMedCrossRefGoogle Scholar
  36. 36.
    Bacaner M, Hoey M, Ikenouchi H, Berry W. Inotropic and chronotropic actions by fatty acids which increase intracellular calcium and shortening in cardiac myocytes.Circulation 1991; 84:II-173.Google Scholar
  37. 37.
    Sirianni AJ, Osterhoudt KC, Calello DP, et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of buproprion and lamotrigine.Ann Emerg Med 2008;51:412–415.PubMedCrossRefGoogle Scholar
  38. 38.
    Krieglstein J, Meffert A, Niemeyer DH. Influence of emulsified fat on chlorpromazine availability in rabbit blood.Experimentia 1974;30:924–926.CrossRefGoogle Scholar
  39. 39.
    Cave G, Harvey MG, Castle CD. Intralipid ameliorates thiopentone induced respiratory depression in rats: investigative pilot study.Emerg Med Australas 2005;17:180–181.PubMedCrossRefGoogle Scholar
  40. 40.
    Goor Y, Goor O, Shaltiel C. A lipid emulsion reduces mortality from clomipramine overdose in rats.Vet and Human Tox 2002;44:30.Google Scholar
  41. 41.
    Harvey M, Cave G. Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity.Ann Emerg Med 2007;49:178–185.PubMedCrossRefGoogle Scholar
  42. 42.
    Minton NA, Goode AG, Henry JA. The effect of a lipid suspension on amitriptyline disposition.Arch Toxicol 1987;60:467–469.PubMedCrossRefGoogle Scholar
  43. 43.
    Tebbutt S, Harvey M, Nicholson T, Cave G. Intralipid prolongs survival in a rat model of verapamil toxicity.Acad Emerg Med 2006;13:134–139.PubMedCrossRefGoogle Scholar
  44. 44.
    Bania TC, Chu J, Perez E, Su M, Hahn I. Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline.Acad Emerg Med 2007;14:105–111.PubMedGoogle Scholar
  45. 45.
    Cave G, Harvey MG, Castle CD. The role of fat emulsion therapy in a rodent model of propranolol toxicity: a preliminary study.J Med Toxicol 2006;2:4–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Bania TC, Chu J, Stolbach A. The effect of intralipid on organophosphate toxicity in mice.Acad Emerg Med 2005;12:S12. Ref Type: Abstract.CrossRefGoogle Scholar
  47. 47.
    Masters TN, Glaviano VV. Effects of d,l-propranolol on myocardial free fatty acid and carbohydrate metabolism.J Pharmacol Exper Ther 1969;167:187–193.Google Scholar
  48. 48.
    Kline J, Leonova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine.Crit Care Med 1995;23:1251–1263.PubMedCrossRefGoogle Scholar

Copyright information

© American College of Medical Toxicology 2008

Authors and Affiliations

  1. 1.Department of Emergency MedicineCarolinas Medical CenterCharlotte
  2. 2.Division of Toxicology, Department of Emergency MedicineCarolinas Medical CenterCharlotte

Personalised recommendations